Business Context and Reporting Period
This Form 8-K is a current report filed by Leap Therapeutics, Inc. (noting a discrepancy in the request metadata which listed "Cypherpunk Technologies Inc.") on June 19, 2020. The filing reports on the results of the Company's 2020 Annual Meeting of Stockholders held on June 16, 2020. Leap Therapeutics is an emerging growth company incorporated in Delaware, with its common stock trading on the Nasdaq Global Market under the symbol LPTX.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report regarding corporate governance and voting results rather than a financial statement.
Material Changes and Voting Results
The primary material event reported is the ratification of the following matters at the Annual Meeting:
- Election of Directors: Three Class III director nominees were elected to serve until the 2023 annual meeting.
- Joseph Loscalzo, MD, PhD: 15,131,757 votes for; 1,030,095 votes withheld.
- Nissim Mashiach: 15,729,468 votes for; 432,384 votes withheld.
- Christopher K. Mirabelli, PhD: 15,149,155 votes for; 1,012,697 votes withheld.
- Ratification of Auditors: The appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020, was ratified.
- Votes For: 23,526,321
- Votes Against: 28,036
- Votes Abstaining: 59,592
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting outcomes.
Investor Verification Checklist
- Verify the correct registrant name is Leap Therapeutics, Inc. (LPTX), as the request metadata contained an incorrect company name.
- Confirm the tenure of the newly elected Class III directors extends through the 2023 annual meeting.
- Review the full proxy statement for detailed biographies of the elected directors and the rationale for the auditor selection.
- Note the significant number of broker non-votes (7,452,097) recorded for the director elections, which may indicate shares held in street name where brokers lacked discretionary voting power.